Raniogas en es it fr

Raniogas Brand names, Raniogas Analogs

Raniogas Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Raniogas Chemical_Formula


Raniogas RX_link


Raniogas fda sheet

Raniogas FDA

Raniogas msds (material safety sheet)

Raniogas MSDS

Raniogas Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Raniogas Molecular Weight

314.405 g/mol

Raniogas Melting Point

69-70 oC

Raniogas H2O Solubility

24.7 mg/mL

Raniogas State


Raniogas LogP


Raniogas Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Raniogas Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Raniogas Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Raniogas Absorption

Approximately 50% bioavailability orally.

Raniogas side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Raniogas Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Raniogas Organisms Affected

Humans and other mammals